Menu
Back to Journals » Cancer Management and Research » Volume 11
Original Research
Efficacy of dose-adjusted EPOCH plus rituximab/R-CHOP regimens and the prognosis analysis in patients with MYC, BCL2/BCL6 gene copy number gain lymphoma and double-hit lymphoma: results from a single institution retrospective clinical study
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 12,550 | Dovepress* | 9,923+ | 1,391 | 11,314 | |
| PubMed Central* | 2,627 | 585 | 3,212 | ||
| Totals | 12,550 | 1,976 | 14,526 | ||
| *Since 11 February 2019 | |||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 2 | 0 | 0 | 0 | 1 | 1 |
View citations on PubMed Central and Google Scholar